Element Biosciences files US complaint against Illumina over DNA sequencers
MLex Summary: Element Biosciences filed a US complaint accusing Illumina of illegally monopolizing the market for DNA sequencing instruments. According to the complaint, Illumina uses exclusivity agreements, coerces customers into buying...To view the full article, register now.
Already a subscriber? Click here to view full article